Table 1

Patient characteristics

AERDATANonasthmatic
No. n = 15 n = 13 n = 9 
Sex (male:female) 7:8 4:9 5:4 
Median age, y (range) 45 (20-65) 37 (22-76) 34 (22-52) 
Atopic (n) 9/15 10/13 3/9 
Baseline FEV1 (mean % predicted ± SD) 82 ± 9 88 ± 15 NA 
Receiving daily inhaled corticosteroids (n) 15/15 12/13 0/9 
Receiving daily oral corticosteroids (n) 2/15 1/13 0/9 
Receiving daily long-acting β-agonists (n) 10/15 7/13 0/9 
Eosinophils (mean % of blood granulocytes ± SD) 15.1 ± 9.0 10.4 ± 6.0 6.4 ± 2.7 
AERDATANonasthmatic
No. n = 15 n = 13 n = 9 
Sex (male:female) 7:8 4:9 5:4 
Median age, y (range) 45 (20-65) 37 (22-76) 34 (22-52) 
Atopic (n) 9/15 10/13 3/9 
Baseline FEV1 (mean % predicted ± SD) 82 ± 9 88 ± 15 NA 
Receiving daily inhaled corticosteroids (n) 15/15 12/13 0/9 
Receiving daily oral corticosteroids (n) 2/15 1/13 0/9 
Receiving daily long-acting β-agonists (n) 10/15 7/13 0/9 
Eosinophils (mean % of blood granulocytes ± SD) 15.1 ± 9.0 10.4 ± 6.0 6.4 ± 2.7 

NA indicates not applicable.

or Create an Account

Close Modal
Close Modal